Literature DB >> 15806393

[Pharmacology of Sinupret. Recent results on the rational for the Sinupret compound].

C Ismail1.   

Abstract

The herbal medicinal product Sinupret has been successfully used for the treatment of sinusitis for 70 years. In Germany the product is established as a standard in the therapy of sinusitis. The most recent pharmacodynamic findings resulted from close scientific cooperation with Pontus Stierna and co-workers from the Karolinska Institute in Stockholm: Mice were infected intranasally with Streptococcus pneumoniae to induce bacterial rhinosinusitis. Animals were randomized to treatment with ampicillin, dexamethasone, Sinupret, or sham treatment. All groups receiving active treatment showed a reduction in bacterial growth after 4 days and a significant reduction of bacterial growth after 8 days. Similar results were observed regarding histopathology. Initial findings in a sinusitis model in the New Zealand White rabbit confirmed the results observed in the aforementioned studies in mice. Understanding of the pharmacological profile of Sinupret supports the knowledge about the clinical efficacy of this herbal medicinal product.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15806393     DOI: 10.1007/s00106-005-1235-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  5 in total

Review 1.  [Profile and effectiveness of a phytogenic combination preparation for treatment of sinusitis].

Authors:  R W März; C Ismail; M A Popp
Journal:  Wien Med Wochenschr       Date:  1999

2.  [The effectiveness and toxicity of a plant secretolytic agent and its component drugs].

Authors:  G Chibanguza; R März; W Sterner
Journal:  Arzneimittelforschung       Date:  1984

3.  Tracheal phenol red secretion, a new method for screening mucosecretolytic compounds.

Authors:  H Engler; I Szelenyi
Journal:  J Pharmacol Methods       Date:  1984-06

4.  Enhanced resistance to Sendai virus infection in DBA/2J mice with a botanical drug combination (Sinupret).

Authors:  M Schmolz; D Ottendorfer; R W März; C Sieder
Journal:  Int Immunopharmacol       Date:  2001-09       Impact factor: 4.932

5.  Surveillance study of Sinupret in comparison with data of the Mainz birth registry.

Authors:  Chaim Ismail; Awi Wiesel; Reinhard W März; Annette Queisser-Luft
Journal:  Arch Gynecol Obstet       Date:  2002-05-15       Impact factor: 2.344

  5 in total
  4 in total

1.  The impact of Sambucus nigra L. extract on inflammation, oxidative stress and tissue remodeling in a rat model of lipopolysaccharide-induced subacute rhinosinusitis.

Authors:  C N Tiboc Schnell; Gabriela Adriana Filip; N Decea; R Moldovan; R Opris; S C Man; B Moldovan; L David; F Tabaran; D Olteanu; A M Gheldiu; I Baldea
Journal:  Inflammopharmacology       Date:  2021-04-21       Impact factor: 4.473

Review 2.  Phytoneering: a new way of therapy for rhinosinusitis.

Authors:  D Passali; J Cambi; F M Passali; L M Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-02       Impact factor: 2.124

3.  Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis.

Authors:  Rainer Jund; Martin Mondigler; Holger Stammer; Pontus Stierna; Claus Bachert
Journal:  Acta Otolaryngol       Date:  2015-01       Impact factor: 1.494

4.  Preclinical evaluation of Luffa operculata Cogn. and its main active principle in the treatment of bacterial rhinosinusitis.

Authors:  Leonardo Silva; Henrique Olival Costa; Flávia Coelho de Souza; Elaine Monteiro Cardoso Lopes; Suely Mitoi Ykko Ueda
Journal:  Braz J Otorhinolaryngol       Date:  2016-12-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.